These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 15558786

  • 1. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A, Fanger G, Khan A, Rock KL, Xu B.
    Cancer; 2004 Dec 25; 102(6):368-72. PubMed ID: 15558786
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.
    Diagn Cytopathol; 2009 Jul 25; 37(7):475-8. PubMed ID: 19217055
    [Abstract] [Full Text] [Related]

  • 3. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
    Kanner WA, Galgano MT, Stoler MH, Mills SE, Atkins KA.
    Int J Gynecol Pathol; 2008 Oct 25; 27(4):491-5. PubMed ID: 18753974
    [Abstract] [Full Text] [Related]

  • 4. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW, Papadimos DJ, Walsh MD.
    Cancer Cytopathol; 2014 Apr 25; 122(4):307-12. PubMed ID: 24421220
    [Abstract] [Full Text] [Related]

  • 5. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.
    Bhargava R, Beriwal S, Dabbs DJ.
    Am J Clin Pathol; 2007 Jan 25; 127(1):103-13. PubMed ID: 17145637
    [Abstract] [Full Text] [Related]

  • 6. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S, Ferro P, Bacigalupo B, Dessanti P, Pronzato P, Franceschini MC, Pratticò L, Carletti AM, Canessa PA, Fontana V, Fais F, Pistillo MP, Fedeli F.
    Diagn Mol Pathol; 2008 Mar 25; 17(1):28-33. PubMed ID: 18303409
    [Abstract] [Full Text] [Related]

  • 7. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW, Koivurinne K.
    Cytopathology; 2008 Aug 25; 19(4):218-23. PubMed ID: 17916095
    [Abstract] [Full Text] [Related]

  • 8. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC, Su YC, Wang SL, Chai CY.
    Kaohsiung J Med Sci; 2007 Jul 25; 23(7):325-31. PubMed ID: 17606426
    [Abstract] [Full Text] [Related]

  • 9. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 10. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH.
    Saudi Med J; 2008 Jul 25; 29(7):957-61. PubMed ID: 18626520
    [Abstract] [Full Text] [Related]

  • 11. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
    Ramalingam P, Middleton LP, Tamboli P, Troncoso P, Silva EG, Ayala AG.
    Ann Diagn Pathol; 2003 Apr 25; 7(2):112-9. PubMed ID: 12715337
    [Abstract] [Full Text] [Related]

  • 12. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS, Lindner JL, Lin X, Liu YL, Silverman JF.
    Diagn Cytopathol; 2006 Dec 25; 34(12):801-6. PubMed ID: 17115439
    [Abstract] [Full Text] [Related]

  • 13. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC, Hsu YC, Chai CY.
    Kaohsiung J Med Sci; 2006 Jan 25; 22(1):14-9. PubMed ID: 16570563
    [Abstract] [Full Text] [Related]

  • 14. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov 25; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA, Bastacky SI, Myers EN, Hunt JL.
    Laryngoscope; 2005 Jun 25; 115(6):1097-100. PubMed ID: 15933529
    [Abstract] [Full Text] [Related]

  • 16. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W, Michael CW.
    Diagn Cytopathol; 2007 Jun 25; 35(6):370-5. PubMed ID: 17497661
    [Abstract] [Full Text] [Related]

  • 17. Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer.
    Janku F, Kleibl Z, Novotny J, Tesarova P, Petruzelka L, Matous B.
    Neoplasma; 2004 Jun 25; 51(3):204-8. PubMed ID: 15254674
    [Abstract] [Full Text] [Related]

  • 18. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV, Nesland JM, Davidson B.
    Am J Surg Pathol; 2006 Jul 25; 30(7):878-82. PubMed ID: 16819331
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
    Bayrak R, Yenidünya S, Haltas H.
    Pathol Res Pract; 2011 Mar 15; 207(3):156-60. PubMed ID: 21282015
    [Abstract] [Full Text] [Related]

  • 20. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M, Haun M, Massoner A, Krugmann J, Müller-Holzner E, Hack R, Hilbe W, Marth C, Duba HC, Gastl G, Grünewald K.
    J Clin Oncol; 2004 Feb 01; 22(3):474-83. PubMed ID: 14752070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.